Recombinant Human MAP3K10 Protein: Research Guide & Protocol
Recombinant Human MAP3K10 Protein: Research Guide & Protocol
Recombinant Human MAP3K10 Protein is a key research reagent enabling scientists to investigate mixed-lineage kinase and JNK/MAPK signaling cascades in vitro with well-defined purity and activity.
- Product Name
- Recombinant Human MAP3K10 Protein
- SKU
- rp377332
- Protein Family
- MAP3K / Mixed-Lineage Kinase (MLK) family
- Primary Signaling Role
- Activates JNK and p38 MAPK pathways downstream
- Expression System
- Recombinant (refer to product datasheet for host system details)
- Recommended Storage
- -80°C; avoid repeated freeze-thaw cycles
- Intended Use
- Research use only (RUO); not for diagnostic or therapeutic use
Biological Background of MAP3K10
MAP3K10, also known as Mixed-Lineage Kinase 2 (MLK2), is a serine/threonine protein kinase belonging to the MAP kinase kinase kinase (MAP3K) superfamily. It plays a central role in the activation of downstream mitogen-activated protein kinase (MAPK) cascades, most notably the c-Jun N-terminal kinase (JNK) and p38 MAPK pathways.
MAP3K10 is widely expressed in neuronal tissues and is implicated in cellular stress responses, apoptosis, and neurodegeneration. As an upstream regulator, MAP3K10 phosphorylates and activates MAP2K4 (MKK4) and MAP2K7 (MKK7), which subsequently activate JNK. This signaling axis is relevant to research in neurodegenerative diseases, cancer biology, and inflammatory responses.
Structural features of MAP3K10 include an N-terminal SH3 domain, a kinase catalytic domain, a leucine zipper motif facilitating dimerization, and a CRIB (Cdc42/Rac interactive binding) domain enabling small GTPase-mediated regulation. Understanding these domains is essential when designing experiments using recombinant MAP3K10 protein.
Protein Handling and Reconstitution Protocol
Proper handling of Recombinant Human MAP3K10 Protein is critical to preserving enzymatic activity and ensuring reproducible results. Follow the steps below upon receipt:
- Upon receipt: Immediately transfer the vial to -80°C if not used immediately. Do not store at -20°C for extended periods.
- Reconstitution: Briefly centrifuge the vial before opening to consolidate the lyophilized material. Reconstitute in the buffer recommended on the product datasheet (typically sterile phosphate-buffered saline with a carrier protein such as 0.1% BSA). Allow the solution to equilibrate for 10 minutes at room temperature before use.
- Aliquoting: Prepare single-use aliquots immediately after reconstitution to minimize freeze-thaw cycles. Each freeze-thaw cycle may reduce protein activity.
- Working concentration: Determine empirically for each assay format. Refer to the product datasheet for guidance on recommended starting concentrations.
- Avoid: Vortexing the reconstituted protein; instead, mix gently by pipetting. Do not use detergents unless specified.
Note: Always consult the most current product datasheet (SKU: rp377332) provided by Aladdin Scientific for lot-specific reconstitution instructions and quality control data.
Experimental Applications
Recombinant Human MAP3K10 Protein is suitable for a range of biochemical and cell biology research applications, including but not limited to:
- In vitro kinase assays: MAP3K10 can be used to phosphorylate downstream substrates such as MKK4 and MKK7 in cell-free systems to study kinase activity, inhibitor screening, or substrate specificity.
- Protein-protein interaction studies: The SH3, leucine zipper, and CRIB domains of MAP3K10 mediate interactions with regulatory proteins (e.g., Cdc42, Rac1). Pull-down and co-immunoprecipitation assays can be performed using the recombinant protein.
- Western blot and ELISA standards: Recombinant MAP3K10 serves as a positive control or standard in immunodetection assays to validate antibody specificity.
- Structural and biophysical studies: The purified protein supports crystallography, SPR (surface plasmon resonance), or ITC (isothermal titration calorimetry) experiments aimed at characterizing inhibitor binding.
- Drug discovery and inhibitor screening: MAP3K10 is a potential therapeutic target in neurodegeneration and oncology; the recombinant protein supports compound library screening in biochemical formats.
Always validate assay conditions empirically and include appropriate positive and negative controls in every experiment.
Quality Control and Purity Considerations
Aladdin Scientific's Recombinant Human MAP3K10 Protein (rp377332) is manufactured under stringent quality control processes. Researchers should review the certificate of analysis (CoA) provided with each lot for the following parameters:
- Purity: Assessed by SDS-PAGE and/or HPLC; expected purity and apparent molecular weight should match the datasheet specifications.
- Biological activity: Confirmed by in vitro kinase activity assay demonstrating phosphorylation of a validated substrate under defined conditions.
- Endotoxin level: Verified by LAL (Limulus Amebocyte Lysate) assay; low endotoxin is especially critical for cell-based assays.
- Sterility and formulation: Check buffer composition, pH, and any carrier proteins or stabilizers present in the formulation as these may affect downstream assays.
If the protein does not perform as expected, contact Aladdin Scientific technical support, providing the lot number, storage history, and assay conditions for troubleshooting assistance.
Troubleshooting Common Issues
The following troubleshooting guide addresses common challenges when working with Recombinant Human MAP3K10 Protein:
| Issue | Possible Cause | Recommended Action |
|---|---|---|
| Low or no kinase activity | Protein degradation due to improper storage or excessive freeze-thaw cycles | Use freshly reconstituted aliquots stored at -80°C; limit freeze-thaw to once |
| Unexpected bands on SDS-PAGE | Protein aggregation or degradation; contaminating proteins | Verify lot CoA; centrifuge sample before loading; check reducing vs. non-reducing conditions |
| High background in kinase assay | Excess ATP, non-specific phosphorylation, or endotoxin contamination | Optimize ATP concentration; include no-enzyme control; use low-endotoxin-grade reagents |
| Poor reproducibility between experiments | Inconsistent reconstitution or working concentration | Prepare aliquots of consistent volume; use calibrated pipettes; standardize assay conditions |
Frequently asked questions
What is MAP3K10 and why is it an important research target?
MAP3K10 (also called MLK2) is a serine/threonine kinase that activates the JNK and p38 MAPK pathways, which regulate apoptosis, stress responses, and neurodegeneration. It is studied as a potential drug target in neurodegenerative diseases and cancer. Recombinant Human MAP3K10 Protein enables in vitro mechanistic and inhibitor studies.
How should Recombinant Human MAP3K10 Protein be stored to maintain activity?
The protein should be stored at -80°C immediately upon receipt if not used right away. Single-use aliquots should be prepared after reconstitution to avoid repeated freeze-thaw cycles, which can significantly reduce kinase activity. Always consult the product datasheet (SKU: rp377332) for lot-specific storage recommendations.
What applications is Recombinant Human MAP3K10 Protein suitable for?
This protein is suitable for in vitro kinase assays, protein-protein interaction studies (pull-down, co-IP), Western blot and ELISA as a standard or positive control, structural and biophysical studies (SPR, ITC, crystallography), and drug discovery inhibitor screening. It is for research use only and not intended for diagnostic or therapeutic applications.
How do I reconstitute Recombinant Human MAP3K10 Protein?
Briefly centrifuge the vial before opening. Reconstitute using the buffer specified on the product datasheet, typically sterile PBS supplemented with a carrier protein such as 0.1% BSA. Allow the reconstituted protein to equilibrate at room temperature for approximately 10 minutes before use, and mix gently by pipetting—do not vortex.
What controls should be included when performing kinase assays with MAP3K10?
Always include a no-enzyme (buffer-only) negative control to assess background phosphorylation and a heat-inactivated protein control to confirm that signal is enzyme-dependent. A positive control using a known active kinase of the same family or a validated substrate with confirmed phosphorylation is also recommended to validate assay performance.
References
- Aladdin Scientific Product Datasheet: Recombinant Human MAP3K10 Protein, SKU rp377332. Aladdin Scientific.
- Bhatt DL et al. Mixed lineage kinases: a target for neuroprotection. Refer to primary literature for MAP3K10/MLK2 biology — specific author names and publication details not available in source material.
- Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation. General MAPK pathway reference — verify specific edition and journal details independently.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
